Karolinska Development - Q4 and 2016 Year-End Report - invitation to conference call and webcast

STOCKHOLM - FEBRUARY 22, 2017. Karolinska Development AB (Nasdaq Stockholm: KDEV) will publish its Q4 and 2016 Year-End Report on February 28, 2017. The company will also host a conference call and an online presentation on the same day at 14.00 CET.

Please dial in at one of the following numbers a few minutes before the start of the conference call:

• From Sweden: [phone]
• From the US: [phone]
• From the UK: [phone]

The presentation will also be webcast and can be accessed from the following web address:
http://edge.media-server.com/m/p/bzmwoimv

Host: Jim Van heusden, CEO. 

For further information, please contact:
Jim Van heusden, CEO, Karolinska Development AB
Phone: [phone], e-mail: [e-mail]  

Christian Tange, CFO, Karolinska Development AB
Phone: [phone], e-mail: [e-mail]

David Dible/Mark Swallow/Pip Batty, Citigate Dewe Rogerson
Phone: [phone]; e-mail: [e-mail]

TO THE EDITORS

About Karolinska Development AB
Karolinska Development AB is an investment company focused on identifying medical innovation and investing in the creation and growth of companies developing these assets into differentiated products that will make a difference to patients' lives and provide an attractive return on investment.

Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success.

Karolinska Development has established a portfolio of nine companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases.

The Company is led by a team including investment professionals with strong venture capital backgrounds, experienced company builders and entrepreneurs, with access to a strong global network.

For more information, please visit www.karolinskadevelopment.com

This information is information that Karolinska Development AB (publ) (Nasdaq Stockholm: KDEV) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of Jim Van heusden, at 2 pm CET on 22 February 2017.

Karolinska Development Q4 2016 Invitation PR (ENG)

---

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Karolinska Development AB (publ) via Globenewswire